p19ARF/CDKN2A Antibody Blocking Peptide
Novus Biologicals, part of Bio-Techne | Catalog # NB200-106PEP
Key Product Details
Conjugate
Unconjugated
Applications
Antibody Competition
Product Specifications
Description
A CDKN2A antibody blocking peptide.
Application Notes
This peptide is useful as a blocking peptide for NB200-106. For further blocking peptide related protocol, click here.
Specificity
This peptide is specific for NB200-106 only.
Protein / Peptide Type
Antibody Blocking Peptide
Formulation, Preparation and Storage
NB200-106PEP
Formulation | Peptide dissolved in dH2O. Contains no BSA. |
Preservative | No Preservative |
Concentration | 1.0 mg/ml |
Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Store at -80C. Avoid freeze-thaw cycles. |
Background: p19ARF/CDKN2A
Alternate Names
alternative reading frame, ARF, ARF-INK4a, CDK4I, CDKN2A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2A, cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4), cyclin-dependent kinase inhibitor 2A, isoform 3, cyclin-dependent kinase inhibitor 2A, isoforms 1/2, cyclin-dependent kinase inhibitor protein, INK4, INK4a, Ink4a/Arf, INK4a-ARF, mitochondrial smARF', MTS1, p14, p14ARF, P16, p16(INK4a), p16-INK4, P16INK4A, p16-INK4a, P19, p19, p19Arf, Pctr1
Gene Symbol
Cdkn2a
Additional p19ARF/CDKN2A Products
Product Documents for p19ARF/CDKN2A Antibody Blocking Peptide
Product Specific Notices for p19ARF/CDKN2A Antibody Blocking Peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...